These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12101708)

  • 1. [Merits of multidisciplinary treatment in lung cancer].
    Kawahara M
    Nihon Rinsho; 2002 May; 60 Suppl 5():433-7. PubMed ID: 12101708
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How to take into account the cost effectiveness parameters in the management of bronchial carcinoma?].
    Vergnenègre A
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S17-10S20. PubMed ID: 17127955
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lung cancer: centralisation of multidisciplinary treatment].
    Postmus PE
    Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1382-4. PubMed ID: 17668598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Informed consent, QOL and cost benefit in the treatment of lung cancer].
    Kubota K
    Nihon Rinsho; 2000 May; 58(5):1153-7. PubMed ID: 10824566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the care of lung cancer patients: a multidisciplinary approach.
    Gradishar WJ; Bitran JD
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1023-5. PubMed ID: 1962773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Function and responsibility of an interdisciplinary tumor center. Need for a "cancer center" for multimodal therapy concepts].
    Neubauer A; Wolf M; Engenhart-Cabillic R; Rothmund M
    Dtsch Med Wochenschr; 2002 Apr; 127(17):901-6. PubMed ID: 12148343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis of cancer treatment costs: another tool for oncology managers.
    Chirikos TN; Ruckdeschel JC; Krischer JP
    J Oncol Manag; 2001; 10(3):11-7. PubMed ID: 11548179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis.
    Ferguson MK
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1935-42. PubMed ID: 14688709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness and lung cancer clinical trials.
    Du W; Reeves JH; Gadgeel S; Abrams J; Peters WP
    Cancer; 2003 Oct; 98(7):1491-6. PubMed ID: 14508837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer management in limited resource settings: guidelines for appropriate good care.
    Macbeth FR; Abratt RP; Cho KH; Stephens RJ; Jeremic B;
    Radiother Oncol; 2007 Feb; 82(2):123-31. PubMed ID: 17239979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of managing lung cancer in Canada.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):147-53. PubMed ID: 8608046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers.
    Porter GA; Cantor SB; Walsh GL; Rusch VW; Leung DH; DeJesus AY; Pollock RE; Brennan MF; Pisters PW
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1366-72. PubMed ID: 15115994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of multidisciplinary lung cancer practice.
    Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
    Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Requirement for multiple-facility hospital structures to meet the needs of lung cancer patients].
    Lebeau B; Chouaid C
    Rev Mal Respir; 2001 Feb; 18(1):17-9. PubMed ID: 14639172
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention, diagnosis, therapy, and follow-up of lung cancer].
    Goeckenjan G; Sitter H; Thomas M; Branscheid D; Flentje M; Griesinger F; Niederle N; Stuschke M; Blum T; Deppermann KM; Ficker JH; Freitag L; Lübbe AS; Reinhold T; Späth-Schwalbe E; Ukena D; Wickert M; Wolf M; Andreas S; Auberger T; Baum RP; Baysal B; Beuth J; Bickeböller H; Böcking A; Bohle RM; Brüske I; Burghuber O; Dickgreber N; Diederich S; Dienemann H; Eberhardt W; Eggeling S; Fink T; Fischer B; Franke M; Friedel G; Gauler T; Gütz S; Hautmann H; Hellmann A; Hellwig D; Herth F; Heussel CP; Hilbe W; Hoffmeyer F; Horneber M; Huber RM; Hübner J; Kauczor HU; Kirchbacher K; Kirsten D; Kraus T; Lang SM; Martens U; Mohn-Staudner A; Müller KM; Müller-Nordhorn J; Nowak D; Ochmann U; Passlick B; Petersen I; Pirker R; Pokrajac B; Reck M; Riha S; Rübe C; Schmittel A; Schönfeld N; Schütte W; Serke M; Stamatis G; Steingräber M; Steins M; Stoelben E; Swoboda L; Teschler H; Tessen HW; Weber M; Werner A; Wichmann HE; Irlinger Wimmer E; Witt C; Worth H;
    Pneumologie; 2010 Mar; 64 Suppl 2():e1-164. PubMed ID: 20217630
    [No Abstract]   [Full Text] [Related]  

  • 18. Practical issues in the management of the patient with small cell lung cancer.
    Govindan R; Ihde DC
    Chest Surg Clin N Am; 1997 Feb; 7(1):167-81. PubMed ID: 9001763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research.
    Grutters JP; Pijls-Johannesma M; Ruysscher DD; Peeters A; Reimoser S; Severens JL; Lambin P; Joore MA
    Cancer Treat Rev; 2010 Oct; 36(6):468-76. PubMed ID: 20303217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.